Cargando…

Human papillomavirus type 16 (HPV-16) IgG antibody among women of reproductive age presenting at a healthcare facility in Central Nigeria: a pilot study

Approximately, 70% of cervical cancer cases worldwide are attributable to HPV-16 and HPV-18, with HPV-associated cancers being the second most common infection-related cancers globally. However, there´s paucity of data about this infective agent in Central Nigeria. In a cross-sectional study, we eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adoga, Moses Peter, Reuben, Rine Christopher, Abubakar, Khadijah, Oti, Victor Baba, Zakka, Abigail William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The African Field Epidemiology Network 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783298/ https://www.ncbi.nlm.nih.gov/pubmed/35136466 http://dx.doi.org/10.11604/pamj.2021.40.203.28804

Ejemplares similares

Immune Response to Human Papillomavirus One Year after Prophylactic Vaccination with AS04-Adjuvanted HPV-16/18 Vaccine: HPV-Specific IgG and IgA Antibodies in the Circulation and the Cervix
por: Costa, Ana Paula Ferreira, et al.
Publicado: (2018)

Variants of human papillomaviruses 16 (HPV16) in Uigur women in Xinjiang, China
por: He, Hongchang, et al.
Publicado: (2016)

Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens
por: Lee, Sin Hang, et al.
Publicado: (2009)

Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes
por: Fontan, Christian T., et al.
Publicado: (2020)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Human papillomavirus (HPV) 16 infection is not detected in rectal carcinoma
por: Martins, Sandra F., et al.
Publicado: (2020)

More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population
por: Marais, Dianne J, et al.
Publicado: (2006)

Human papillomavirus 16 (HPV16) enhances tumor growth and cancer stemness of HPV-negative oral/oropharyngeal squamous cell carcinoma cells via miR-181 regulation
por: Hee Lee, Sung, et al.
Publicado: (2015)

Antibodies against human papillomavirus type 16 (HPV-16) and conjunctival squamous cell neoplasia in Uganda
por: Waddell, K, et al.
Publicado: (2003)

Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women
por: Ramanakumar, Agnihotram V, et al.
Publicado: (2010)

Prevalence of Human Papillomavirus (HPV)-16 in Different Dental Infections in the Lebanese Population
por: Khalil, Wael, et al.
Publicado: (2023)

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors
por: Damm, Oliver, et al.
Publicado: (2009)

In silico prediction of structural changes in human papillomavirus type 16 (HPV16) E6 oncoprotein and its variants
por: Rodríguez-Ruiz, Hugo Alberto, et al.
Publicado: (2019)

Heterogeneity in IgG‐CD16 signaling in infectious disease outcomes
por: Gonzalez, Joseph C., et al.
Publicado: (2022)

Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18
por: Layman, Hans, et al.
Publicado: (2020)

Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalence
por: Namujju, Proscovia B, et al.
Publicado: (2011)

Effects of human papillomavirus (HPV) type 16 oncoproteins on the expression of involucrin in human keratinocytes
por: Gyöngyösi, Eszter, et al.
Publicado: (2012)

Analysis of Human Papillomavirus (HPV) 16 Variants Associated with Cervical Infection in Italian Women
por: Martinelli, Marianna, et al.
Publicado: (2020)

Detection of Human Papillomavirus 16-Specific IgG and IgM Antibodies in Patient Sera: A Potential Indicator of Oral Squamous Cell Carcinoma Risk Factor
por: Kerishnan, Jesinda P., et al.
Publicado: (2016)

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada
por: Kohli, Michele, et al.
Publicado: (2012)

Phylogeny and Classification of Human Papillomavirus (HPV)16 and HPV18 Variants Based on E6 and L1 genes in Tunisian Women with Cervical Lesions
por: Jendoubi-Ferchichi, Mouna, et al.
Publicado: (2018)

Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
por: BIAN, MEI-LU, et al.
Publicado: (2013)

Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?
por: Sung, Yeoun Eun, et al.
Publicado: (2016)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

p53 Is Regulated in a Biphasic Manner in Hypoxic Human Papillomavirus Type 16 (HPV16)-Positive Cervical Cancer Cells
por: Zhuang, Linhan, et al.
Publicado: (2020)

Characterization of the Human Papillomavirus 16 Oncogenes in K14HPV16 Mice: Sublineage A1 Drives Multi-Organ Carcinogenesis
por: Cochicho, Daniela, et al.
Publicado: (2022)

Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis
por: Yang, Ruwen, et al.
Publicado: (2019)

Frequency of Human Papillomavirus (HPV) 16 and 18 Detection in Paraffin- Embedded Laryngeal Carcinoma Tissue
por: Hosseini, Seyed Zinab, et al.
Publicado: (2017)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand
por: Khunamornpong, Surapan, et al.
Publicado: (2016)

CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes
Publicado: (1988)

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis
por: Golden, Allison, et al.
Publicado: (2016)

Folate Repletion after Deficiency Induces Irreversible Genomic and Transcriptional Changes in Human Papillomavirus Type 16 (HPV16)-Immortalized Human Keratinocytes
por: Savini, Claudia, et al.
Publicado: (2019)

Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus–Based Screening in Mexico
por: Torres-Ibarra, Leticia, et al.
Publicado: (2019)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)

CD16 Expression on Monocytes in Healthy Individuals but Not Schistosome-Infected Patients Is Positively Associated with Levels of Parasite-Specific IgG and IgG1
por: Appleby, Laura J., et al.
Publicado: (2014)

The transcriptional regulator gene E2 of the Human Papillomavirus (HPV) 16 influences the radiosensitivity of cervical keratinocytes
por: Lindel, Katja, et al.
Publicado: (2012)

Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice
por: Whitehead, Mark, et al.
Publicado: (2014)

Human papillomavirus genotype and prognosis of cervical cancer: Favorable survival of patients with HPV16-positive tumors
por: Onuki, Mamiko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cl867bqs66j1j2i3j8u2fmmbgh